openPR Logo
Press release

OnderLaw Reaches $8.9 Billion Agreement with Johnson & Johnson over Talc-Related Cancer Claims

04-05-2023 10:17 AM CET | Politics, Law & Society

Press release from: OnderLaw, LLC

$8.9 Billion Resolution Reached for J&J Talc Cancer Claims

$8.9 Billion Resolution Reached for J&J Talc Cancer Claims

Today marks a monumental day as OnderLaw, LLC announces the successful resolution of tens of thousands of Johnson & Johnson talc-related gynecologic cancer and mesothelioma claims. J&J will create an $8.9 billion bankruptcy trust, paying out approximately $12.08 billion over time to compensate both current and future victims of talc-related gynecologic cancers and mesothelioma.

"For more than a decade, we have stood with hard-working Americans against J&J, one of the most powerful corporations in the world. This has not been an easy fight. Through the years, while we've been on the legal battlefield, many of our clients have been fighting for their lives, medical bills forced victims to lose their homes and savings, and far too many families have lost mothers, wives, husbands and fathers to gynecologic cancers and mesothelioma caused by J&J's talc," said Jim Onder, managing partner of OnderLaw, who filed the second talc-related cancer lawsuit in the country in 2014. "This victory is bittersweet, but it is a victory, indeed," he added.

An estimated 70,000 plaintiffs have filed claims against the baby powder manufacturer after studies linked talc to ovarian and other gynecologic cancers, as well as to mesothelioma. In the decade since talc litigation began, J&J's own records and a Reuters investigation revealed that not only did J&J know of the dangers, but they went to considerable effort to hide talc risks from unsuspecting consumers.

Onder and his St. Louis-based practice have been at the forefront of the battle. "This is an incredible milestone, and we could not have achieved it without the unwavering support and perseverance of the brave individuals and families who stood with us to demand change and accountability."

J&J filed a controversial bankruptcy referred to as a Texas Two-Step in 2021, shifting their talc liability into an entity called LTL Management. Last month, their bankruptcy bid was rejected by the Third Circuit Court of Appeals. Under this new agreement, however, J&J will file a new and second bankruptcy with the support of over 75% of all claimants nationwide. Payment grids and criteria are still being finalized. Once approved, J&J has committed to paying all current claimants within one year.

Because these cancers can take years to develop after exposure, the trust also establishes a pathway for those who are diagnosed in the future to avoid years of litigation and receive compensation directly.

In addition, even more importantly according to Onder, J&J has agreed to remove talc from store shelves worldwide, eliminating a deadly cancer risk for millions of people.

"No amount of money can truly compensate for the pain and suffering that our clients and their loved ones have endured, but I hope this plan brings closure and peace. They have waited far too long for resolution," said Onder. "Together, however, we have made a difference, and for that I am honored and proud."

OnderLaw, LLC
110 E. Lockwood Ave.
St. Louis, MO 63119
www.onderlaw.com
(314)963-9000
Press Contact Amanda Christmann
623-299-1074
christmann@onderlaw.com

OnderLaw, LLC is a mass tort and personal injury law firm based in St. Louis, Missouri with offices in Huntington Beach, CA and Nashville, TN. The firm represents tens of thousands of clients in litigations against some of the world's most powerful corporations. Our distinguished attorneys have been recognized by the most prestigious legal organizations in the country for results we have achieved for individual clients as well as the overall scope of our law practice, as well as the dedication with which we approach each and every case.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release OnderLaw Reaches $8.9 Billion Agreement with Johnson & Johnson over Talc-Related Cancer Claims here

News-ID: 3000184 • Views:

More Releases for J&J

Thriller Author J. J. Fauser (“Family Business”) donates complete 2021 profi …
Internationally aspiring thriller author James Jack Fauser has announced to donate the complete profit of the year 2021 from his debut novel “Family Business”. The money is meant for homeless people. J. J. Fauser whos’ thriller “Family Business” has already been announced by the “National Times USA” and the “Herald Tribune” as the “most innovative thriller 2021”, will support with his donation the homeless projects of The Salvation Army, Caritas, Diakonie
Global Plasma Sterilizer Market 2019 - J&J, HMTS, Shinva, Medivators, Laoken
This new report by Eon Market Research, titled “Global Plasma Sterilizer Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Plasma Sterilizer industry at a global as well as regional and country level. Key facts analyzed in this report include the Plasma Sterilizer market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses
Surgical Stapler Market 2018 Outlook by BD, J&J, CONMED, CryoLife, Medtronic.
Surgical Stapler Market report offers a comprehensive valuation of the marketplace. It does so via in-depth comprehensions, grateful market growth by pursuing past developments, and studying the present situation and future forecasts based on progressive and likely areas. Each research report supports as a depository of analysis and data for each and every side of the industry, including but not limited to: Regional markets, types, applications, technology developments and the
Latest Report on: Velcade Market Report 2018-2025 J&J, Takeda
A market study "Global Velcade Market" examines the performance of the Velcade market 2018. It encloses an in-depth Research of the Velcade market state and the competitive landscape globally. This report analyzes the potential of Velcade market in the present and the future prospects from various angles in detail. The Global Velcade Market 2018 report includes Velcade market Revenue, market Share, Velcade industry volume, market Trends, Velcade Growth aspects. A wide
Latest Report on: Bortezomib Market Report 2018-2025 J&J, Takeda
A market study "Global Bortezomib Market" examines the performance of the Bortezomib market 2018. It encloses an in-depth Research of the Bortezomib market state and the competitive landscape globally. This report analyzes the potential of Bortezomib market in the present and the future prospects from various angles in detail. The Global Bortezomib Market 2018 report includes Bortezomib market Revenue, market Share, Bortezomib industry volume, market Trends, Bortezomib Growth aspects. A wide
Demineralized Allografts Market 2017 - J &J, Zimmer, Medtronic, Straumann, RTI S …
Apex Research, recently published a detailed market research study focused on the "Demineralized Allografts Market" across the global, regional and country level. The report provides 360° analysis of "Demineralized Allografts Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Demineralized Allografts industry, and estimates the future trend of Demineralized Allografts market on